相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users
Lynn R. Webster et al.
Drugs in research & development (2013)
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats
Alexa A. Wakley et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Nicotine and endogenous opioids: Neurochemical and pharmacological evidence
Maria Hadjiconstantinou et al.
NEUROPHARMACOLOGY (2011)
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers
Ziva D. Cooper et al.
PSYCHOPHARMACOLOGY (2010)
Central antinociception induced by μ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB1 receptor
Daniela da Fonseca Pacheco et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol
Joshua A. Lile et al.
PSYCHOPHARMACOLOGY (2009)
Behavioral sensitization to Δ9-tetrahydrocannabinol and cross-sensitization with morphine:: differential changes in accumbal shell and core dopamine transmission
Cristina Cadoni et al.
JOURNAL OF NEUROCHEMISTRY (2008)
μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
Minoru Hojo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Blockade of THC-Seeking Behavior and relapse in monkeys by the cannabinoid CB1-Receptor antagonist rimonabant
Zuzana Justinova et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Blunted psychotomimetic and amnestic effects of Δ-9-tetrahydrocannabinol in frequent users of cannabis
Deepak Cyril D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans
Deepak Cyril D'Souza et al.
PSYCHOPHARMACOLOGY (2008)
Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys:: discrimination and antinociception
Jun-Xu Li et al.
PSYCHOPHARMACOLOGY (2008)
Opioid antagonism of cannabinoid effects: Differences between marijuana smokers and nonmarijuana smokers
Margaret Haney
NEUROPSYCHOPHARMACOLOGY (2007)
μ opioid and CB1 cannabinoid receptor interactions:: reciprocal inhibition of receptor signaling and neuritogenesis
Carl Rios et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Potentiation of low dose ketamine effects by naltrexone: Potential implications for the pharmacotherapy of alcoholism
John H. Krystal et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems
M Solinas et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Molecular and cellular basis of cannabinoid and opioid interactions
D Viganò et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats
D Braida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Exposure to Δ-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy:: A self-administration study in rats
M Solinas et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens
VM Pickel et al.
NEUROSCIENCE (2004)
Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats
M Navarro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat
MS Spano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Interaction between naltrexone and oral THC in heavy marijuana smokers
M Haney et al.
PSYCHOPHARMACOLOGY (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Gender differences in proenkephalin gene expression response to Δ9-tetrahydrocannabinol in the hypothalamus of the rat
J Corchero et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404
I Del Arco et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn
C Salio et al.
NEUROREPORT (2001)
Behavioural sensitization after repeated exposure to Δ9-tetrahydrocannabinol and cross-sensitization with morphine
C Cadoni et al.
PSYCHOPHARMACOLOGY (2001)
Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects
P Massi et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Chronic treatment with Δ9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin.: Implications for vulnerability to drug addiction
S Lamarque et al.
NEUROPHARMACOLOGY (2001)
Δ9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins:: reduction in morphine withdrawal syndrome without change in rewarding effect
O Valverde et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Conditioned place preference induced by the cannabinoid agonist CP 55,940: Interaction with the opioid system
D Braida et al.
NEUROSCIENCE (2001)
Naltrexone does not block the subjective effects of oral Δ9-tetrahydrocannabinol in humans
SR Wachtel et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Antinociceptive, subjective and behavioral effects of smoked marijuana in humans
MK Greenwald et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Prenatal Δ9-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain:: sex-dependent differences
A Pérez-Rosado et al.
DEVELOPMENTAL BRAIN RESEARCH (2000)